Covered recipient · General Payments record
PHILIP S RUBIN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$7,082.17
- Reported across 201 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Grant | $3,333.00 | 1 |
| Food and Beverage | $513.39 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $3,333.00 | 1 |
| Exact Sciences Corporation | $112.53 | 4 |
| Lilly USA, LLC | $92.32 | 5 |
| Novo Nordisk AS | $55.45 | 3 |
| PFIZER INC. | $55.30 | 3 |
| ABBVIE INC. | $49.49 | 2 |
| DEXCOM, INC. | $40.95 | 2 |
| Neurocrine BioSciences, Inc. | $26.90 | 1 |
| Acerta Pharma LLC | $20.06 | 1 |
| Amgen Inc. | $18.22 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.52 | 1 |
| Merck Sharp & Dohme Corporation | $13.39 | 1 |
| GlaxoSmithKline, LLC. | $13.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.96 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105984961 | CMS |
| ABBVIE INC. | $20.53 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105984963 | CMS |
| Amgen Inc. | $18.22 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117671049 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.06 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104689692 | CMS |
| Dexcom, Inc. | $18.21 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153328109 | CMS |
| Dexcom, Inc. | $22.74 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153328111 | CMS |
| Exact Sciences Corporation | $34.81 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114863402 | CMS |
| Exact Sciences Corporation | $30.08 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114863407 | CMS |
| Exact Sciences Corporation | $18.91 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114863421 | CMS |
| Exact Sciences Corporation | $28.73 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114863427 | CMS |
| GlaxoSmithKline, LLC. | $13.26 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116290503 | CMS |
| Lilly USA, LLC | $18.20 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135319039 | CMS |
| Lilly USA, LLC | $19.13 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135319043 | CMS |
| Lilly USA, LLC | $15.92 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135296367 | CMS |
| Lilly USA, LLC | $22.03 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135319047 | CMS |
| Lilly USA, LLC | $17.04 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135281690 | CMS |
| Medtronic, Inc. | $3,333.00 | 07/11/2024 | Grant | Undisputed | 01/23/2026 | 1112070254 | CMS |
| Merck Sharp & Dohme LLC | $13.39 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141608249 | CMS |
| Neurocrine Biosciences, Inc. | $26.90 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150833890 | CMS |
| Novo Nordisk Inc | $19.13 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096848973 | CMS |
| Novo Nordisk Inc | $18.04 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097125803 | CMS |
| Novo Nordisk Inc | $18.28 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096601723 | CMS |
| PFIZER INC. | $17.94 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131282279 | CMS |
| PFIZER INC. | $18.78 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131437240 | CMS |
| PFIZER INC. | $18.58 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131855043 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.52 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151118269 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.